Forte Biosciences Inc.
13F holders, Q1 2024 (March 31)33holders
2famous investors
$0.70avg. 13F price*
At the end of Q1 2024, 33 institutions reported holding Forte Biosciences Inc. in their 13F filings. The largest holders were Tybourne Capital Management (hk) Ltd. ($2.5M), Perceptive Advisors LLC ($2.3M) and BVF Inc. ($2.1M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Forte Biosciences Inc.
- CUSIP
- 34962G109
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $119K |
| Exits | 4 | $5K |
Ownership 33 holders
| Tybourne Capital Management (hk) Ltd. | 0.43% | No change | 3,624,548 | $2.5M |
| Perceptive Advisors LLC | 0.04% | No change | 3,265,359 | $2.3M |
| BVF Inc. | 0.06% | No change | 2,982,105 | $2.1M |
| Cable Car Capital, LP | 2.10% | No change | 2,031,987 | $1.4M |
| Fred Alger Management, LLC | 0.01% | No change | 1,838,965 | $1.3M |
| Farallon Capital Management, L.L.C. | 0.01% | No change | 1,810,455 | $1.3M |
| BML Capital Management, LLC | 0.82% | No change | 1,761,702 | $1.2M |
| Vanguard Group Inc. | 0.00% | No change | 665,230 | $463K |
| Geode Capital Management, LLC | 0.00% | Add +2.0% | 343,432 | $241K |
| BlackRock Inc. | 0.00% | Reduce -4.1% | 174,858 | $122K |
| ADAR1 Capital Management, LLC | 0.03% | New | 170,510 | $119K |
| Renaissance Technologies | 0.00% | Add +1.8% | 132,100 | $92K |
| State Street Corp. | 0.00% | No change | 41,664 | $29K |
| Two Sigma Investments, LP | 0.00% | Reduce -0.2% | 40,864 | $28K |
| Citadel Advisors | 0.00% | Add +227.5% | 28,220 | $20K |
| Northern Trust Corp. | 0.00% | No change | 26,911 | $19K |
| Two Sigma Advisers, LP | 0.00% | No change | 24,791 | $17K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.2% | 20,774 | $14K |
| Group One Trading LLC | 0.00% | Reduce -8.2% | 14,527 | $10K |
| Aries Wealth Management | 0.00% | No change | 13,000 | $9K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +101.4% | 11,642 | $8K |
| Two Sigma Securities, LLC | 0.00% | Reduce -27.9% | 11,122 | $8K |
| HSBC Holdings PLC | 0.00% | No change | 10,745 | $8K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,080 | $754 |
| Morgan Stanley | 0.00% | No change | 994 | $692 |
| Russell Investments Group, Ltd. | 0.00% | No change | 453 | $317 |
| Wells Fargo & Company | 0.00% | Add +2.0% | 253 | $176 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 0.00% | No change | 193 | $139 |
| REAP Financial Group, LLC | 0.00% | No change | 97 | $68 |
| UBS Group AG | 0.00% | Reduce -77.4% | 33 | $23 |
| JPMorgan Chase & Co. | 0.00% | No change | 17 | $12 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $2 |
| Royal Bank of Canada | 0.00% | New | 137 | $0 |
"% of holder's portfolio" is FORTE BIOSCIENCES INC's weight in each manager's 13F, not the share of Forte Biosciences Inc. the manager owns.